Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-05-25 @ 5:02 AM
Study NCT ID:
NCT00630058
Status:
COMPLETED
Last Update Posted:
2014-05-02
First Post:
2008-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C
Sponsor:
Tanabe Pharma Corporation
Organization: